{
  "thread": {
    "uuid": "22f10d96fc4fc51ff093ff5a1032b2ed59063d65",
    "url": "https://www.bakersfield.com/ap/news/supernus-announces-promising-data-from-open-label-phase-2a-study-of-spn-820-in-adults/article_93ab9b31-c7a6-5d90-8357-4c713763b25c.html",
    "site_full": "www.bakersfield.com",
    "site": "bakersfield.com",
    "site_section": "https://www.bakersfield.com/ap/news/",
    "site_categories": [
      "media"
    ],
    "section_title": "News | bakersfield.com",
    "title": "Supernus Announces Promising Data from Open-Label Phase 2a Study of SPN-820 in Adults with ... | News | bakersfield.com",
    "title_full": "Supernus Announces Promising Data from Open-Label Phase 2a Study of SPN-820 in Adults with ... | News | bakersfield.com",
    "published": "2024-10-17T08:00:00.000+03:00",
    "replies_count": 0,
    "participants_count": 1,
    "site_type": "news",
    "country": "US",
    "main_image": "https://bloximages.newyork1.vip.townnews.com/bakersfield.com/content/tncms/custom/image/d09180fc-6bee-11e7-8b72-ff928e2e17d5.png?resize=600%2C315",
    "performance_score": 0,
    "domain_rank": 9858,
    "domain_rank_updated": "2024-10-15T00:00:00.000+03:00",
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "22f10d96fc4fc51ff093ff5a1032b2ed59063d65",
  "url": "https://www.bakersfield.com/ap/news/supernus-announces-promising-data-from-open-label-phase-2a-study-of-spn-820-in-adults/article_93ab9b31-c7a6-5d90-8357-4c713763b25c.html",
  "ord_in_thread": 0,
  "parent_url": null,
  "author": "Supernus Pharmaceuticals, Inc. - (GLOBE NEWSWIRE)",
  "published": "2024-10-17T08:00:00.000+03:00",
  "title": "Supernus Announces Promising Data from Open-Label Phase 2a Study of SPN-820 in Adults with ... | News | bakersfield.com",
  "text": "Phase 2a study demonstrated rapid and substantial decrease in depressive symptoms SPN-820 was well-tolerated with few adverse events kAmk6>m$!}\\ga_ :D 2 ?@G6=[ 7:CDE\\:?\\4=2DD :?EC246==F=2C >@5F=2E@C @7 >%~#r` 7@C E96 EC62E>6?E @7 56AC6DD:@?k^6>mk^Am kAmk6>mr@>A2?J E@ 9@DE H6342DE E@52J 2E cib_ A]>] t% E@ 5:D4FDD E96 E@A=:?6 52E2k^6>mk^Am kAmk6>m%@A=:?6 C6DF=ED 7C@> !92D6 a3 C2?5@>:K65 5@F3=6\\3=:?5 A=2463@\\4@?EC@==65 DEF5J @7 $!}\\ga_ :? 25F=ED H:E9 EC62E>6?E\\C6D:DE2?E 56AC6DD:@? 6IA64E65 7:CDE\\92=7 a_adk^6>mk^Am kAm#~rz'x{{t[ |5][ ~4E] `f[ a_ac Wv{~qt }t($(x#tX \\\\ $FA6C?FD !92C>246FE:42=D[ x?4] W}2D52Bi $&!}X[ 2 3:@A92C>246FE:42= 4@>A2?J 7@4FD65 @? 56G6=@A:?8 2?5 4@>>6C4:2=:K:?8 AC@5F4ED 7@C E96 EC62E>6?E @7 46?EC2= ?6CG@FD DJDE6> Wr}$X 5:D62D6D[ E@52J 2??@F?465 52E2 7C@> :ED 6IA=@C2E@CJ @A6?\\=236= !92D6 a2 4=:?:42= DEF5J @7 $!}\\ga_ :? 25F=ED H:E9 >2;@C 56AC6DD:G6 5:D@C56C] %96 DEF5J 6I2>:?65 E96 D276EJ 2?5 E@=6C23:=:EJ @7 $!}\\ga_ ac__ >8 8:G6? @?46 6G6CJ b 52JD 2D 2? 25;F?4E:G6 EC62E>6?E E@ E96 4FCC6?E 32D6=:?6 2?E:56AC6DD2?E E96C2AJ[ 2D H6== 2D 2DD6DD65 E96 C2A:5 @?D6E @7 :>AC@G6>6?E :? 56AC6DD:G6 DJ>AE@>D] %96 2?2=JD:D :D 32D65 @? c_ 6?C@==65 DF3;64ED[ @7 H9:49 bg 4@>A=6E65 E96 `_\\52J EC62E>6?E A6C:@5]k^Am kAm$F>>2CJ @7 E96 s2E2k^Am kF=mk=: DEJ=6lQ>2C8:?\\E@AiaAEj E6IE\\2=:8?i;FDE:7JjQmr=:?:42==J >62?:?87F= :>AC@G6>6?E @7 –e]` 2E EH@ 9@FCD 2?5 –h]e 2E s2J `_ @? E96 w2>:=E@? s6AC6DD:@? #2E:?8 $42=6\\e xE6>D Wwp|\\seX E@E2= D4@C6]k^=:mk=: DEJ=6lQ>2C8:?\\E@AiaAEj E6IE\\2=:8?i;FDE:7JjQmr=:?:42==J >62?:?87F= :>AC@G6>6?E @7 –`e]e 2E 7@FC 9@FCD 2?5 –aa]h 2E s2J `_ @? E96 |@?E8@>6CJ ÅD36C8 s6AC6DD:@? #2E:?8 $42=6 W|ps#$X E@E2= D4@C6]k^=:mk=: DEJ=6lQ>2C8:?\\E@AiaAEj E6IE\\2=:8?i;FDE:7JjQm$F:4:52= :562E:@? 564C62D65 3J g_T W`a]dT H:E9 DF:4:52= :562E:@? 2E 32D6=:?6 564C62D65 E@ a]eT H:E9 DF:4:52= :562E:@? 2E s2J `_X]k^=:mk=: DEJ=6lQ>2C8:?\\E@AiaAEj E6IE\\2=:8?i;FDE:7JjQm$!}\\ga_ H2D H6==\\E@=6C2E65 H:E9 76H 25G6CD6 6G6?ED WptDX 2?5 925 2446AE23=6 E@=6C23:=:EJ H:E9 2 5:D4@?E:?F2E:@? C2E6 @7 a]dT 5F6 E@ ptD]k^=:mk=: DEJ=6lQ>2C8:?\\E@AiaAEj E6IE\\2=:8?i;FDE:7JjQm|@DE 4@>>@? ptD C6=2E65 E@ E96 5CF8 :?4=F565 96252496[ ?2FD62[ D@>?@=6?46[ 2?5 5:KK:?6DD] p55:E:@?2= ptD DF49 2D 4@8?:E:G6 5:D@C56C[ 5CJ >@FE9[ 72E:8F6[ ?2D2= 564@?86DE:@?[ 2?5 A2C6DE96D:2 @C2= H6C6 @3D6CG65]k3C ^mk3C ^mk^=:mk^F=m kAm“%96D6 !92D6 a2 52E2 F?56CD4@C6 @FC 36=:67 E92E $!}\\ga_ 92D E96 A@E6?E:2= 2D 2 ?@G6= EC62E>6?E @AE:@? 7@C A2E:6?ED H:E9 56AC6DD:@?[ H:E9 E96 @AA@CEF?:EJ E@ 564C62D6 DJ>AE@>D BF:4 6 D:56 67764ED[” D2:5 y24 A=6E6 6?C@==>6?E :? E96 !92D6 a3 C2?5@>:K65 5@F3=6\\3=:?5 A=2463@\\4@?EC@==65 DEF5J @7 $!}\\ga_ :? 25F=ED H:E9 EC62E>6?E\\C6D:DE2?E 56AC6DD:@? :? }@G6>36C @7 E9:D J62C[ H:E9 E@A=:?6 C6DF=ED 6IA64E65 :? E96 7:CDE 92=7 @7 a_ad]”k^Am kAm(6342DE s6E2:=Dk^Am kAm$FA6C?FD H:== 9@DE 2 4@?76C6?46 42== 2?5 H6342DE E@52J[ ~4E@36C `f[ a_ac[ 2E cib_ A]>] t% E@ 5:D4FDD E96D6 E@A=:?6 C6DF=ED] p =:G6 H6342DE H:E9 AC6D6?E2E:@? D=:56D H:== 36 2G2:=23=6 G:2 k2 9C67lQ9EEADi^^HHH]8=@36?6HDH:C6]4@>^%C24 J8\\\\C\":*q{dwD\\GdG{6:t(2;u4Awb5rD9_FwucysuA@D:8h:r0*dH;f\"eh&r8 Aj !C6D6?E2E:@?D D64E:@? @7 E96 r@>A2?J’D x?G6DE@C #6=2E:@?D H63D:E6 2E k2 9C67lQ9EEADi^^HHH]8=@36?6HDH:C6]4@>^%C24 {Hgy 246FE:42=D[ x?4]k^Am kAmWb_`X gbg\\adh`k^Am kAm@Ck^Am kAmx}'t$%~# r~}%pr%ik^Am kAm!6E6C '@KK@k^Am kAmxr# (6DEH:4 2:=E@iA6E6C]G@KK@oH6DEH:4 QmA6E6C]G@KK@oH6DEH:4 k^2mk^Am kAmk^Am kAmk^Am",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "english",
  "sentiment": "positive",
  "categories": [
    "Health",
    "Science and Technology",
    "Human Interest"
  ],
  "ai_allow": false,
  "webz_reporter": false,
  "external_links": [],
  "external_images": [],
  "entities": {
    "persons": [],
    "organizations": [
      {
        "name": "EC",
        "sentiment": "none"
      }
    ],
    "locations": []
  },
  "syndication": {
    "syndicated": false,
    "syndicate_id": null,
    "first_syndicated": false
  },
  "rating": null,
  "crawled": "2024-10-18T00:16:07.284+03:00",
  "updated": "2024-10-18T00:16:07.284+03:00"
}